Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Virology|August 10, 2018
Mapping an Adeno-associated Virus 9-Specific Neutralizing Epitope To Develop Next-Generation Gene Delivery VectorsApril R Giles, Lakshmanan Govindasamy, Suryanarayan Somanathan, et al.Frontiers in Immunology|August 1, 2020
Isolating Human Monoclonal Antibodies Against Adeno-Associated Virus From Donors With Pre-existing ImmunityApril R Giles, Roberto Calcedo, Anna P Tretiakova, et al.Cellular Immunology|November 10, 2019
TLR9 signaling mediates adaptive immunity following systemic AAV gene therapyScott N Ashley, Suryanarayan Somanathan, April R Giles, et al.Human Gene Therapy|April 4, 2014
Adeno-associated virus serotypes 1, 8, and 9 share conserved mechanisms for anterograde and retrograde axonal transportMichael J Castle, Zachary T Gershenson, April R Giles, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 23, 2018
Deamidation of Amino Acids on the Surface of Adeno-Associated Virus Capsids Leads to Charge Heterogeneity and Altered Vector FunctionApril R Giles, Joshua J Sims, Kevin B Turner, et al.Frontiers in Neurology|December 1, 2022
Kinetics and durability of transgene expression after intrastriatal injection of AAV9 vectorsBradley S Hollidge, Hayley B Carroll, Randolph Qian, et al.Molecular Therapy. Methods & Clinical Development|October 21, 2024
A novel AAV9-dual microRNA-vector targeting <i>GRIK2</i> in the hippocampus as a treatment for mesial temporal lobe epilepsyStéphane J Baudouin, April R Giles, Nick Pearson, et al.Molecular Therapy. Methods & Clinical Development|September 24, 2025
Directed evolution of liver-detargeted AAV vectors for systemic gene delivery to skeletal muscle and heartElad Firnberg, Sigmund K S Tejada, Samantha A Yost, et al.Journal of Virology|October 16, 2023
Characterization and biodistribution of under-employed gene therapy vector AAV7Samantha A Yost, Emre Firlar, Justin D Glenn, et al.Pageof 1